PURPOSE: To investigate the value of contrast-enhanced ultrasound (CEUS) in histologic prediction of focal liver lesions after liver transplantation.
MATERIALS AND METHODS: 10 focal liver lesions in 10 patients after liver transplantation were scanned using CEUS and the CEUS results were compared with the histopathological results.
RESULTS: Among 10 focal liver lesions, 7 proofed to be histopathological benign and 3 lesions proofed to be histopathological malignant. All lesions (100%) were correctly report as benign or malignant in the report of the CEUS examination.
CONCLUSION: CEUS can be helpful in the differentiation of benign and malignant focal liver lesions in patients after liver transplantation and can be used in clinical management of focal liver lesions.
SmajerovaM., PetrasovaH., LittleJ., OvesnaP., AndrasinaT., ValekV., et al., Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysis, World Journal of Gastroenterology: WJG22(38) (2016), 8605–8614.
2.
SeitzK., BernatikT., StrobelD., BlankW., Friedrich-RustM., StrunkH., et al., Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI–a prospective comparison in 269 patients, Ultraschall in der Medizin31(5) (2010), 492–499.
3.
StrobelD., SeitzK., BlankW., SchulerA., DietrichC.von HerbayA., et al., Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial), Ultraschall in der Medizin29(5) (2008), 499–505.
4.
StrobelD., BernatikT., BlankW., SchulerA., GreisC., DietrichC.F., et al., Diagnostic accuracy of CEUS in the differential diagnosis of small (< / = 20 mm) and subcentimetric (< / = 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial, Ultraschall in der Medizin32(6) (2011), 593–597.
5.
SporeaI., BadeaR., PopescuA., SparchezZ., SirliR.L., DanilaM., et al., Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice, Ultraschall in der Medizin35(3) (2014), 259–266.
6.
WelkerM.W., BechsteinW.O., ZeuzemS. and TrojanJ., Recurrent hepatocellular carcinoma after liver transplantation -an emerging clinical challenge, Transpl Int26(2) (2013), 109–118.
7.
DhamijaE. and PaulS.B., Role of contrast enhanced ultrasound in hepatic imaging, Trop Gastroenterol35(3) (2014), 141–151.
8.
YueW.W., WangS., XuH.X., SunL.P., GuoL.H., BoX.W., LiX.L., ZhaoC.K., WangD. and LiuB.J., Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer, Clin Hemorheol Microcirc64(2) (2016), 177–188.
GreisC., Ultrasound contrast agents as markers of vascularity and microcirculation, Clin Hemorheol Microcirc43(1-2) (2009), 1–9.
11.
GreisC., Summary of technical principles of contrast sonography and future perspectives, Der Radiologe51(6) (2011), 456–461.
12.
ClaudonM., CosgroveD., AlbrechtT., BolondiL., BosioM., CalliadaF., et al., Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008, Ultraschall in der Medizin29(1) (2008), 28–44.
13.
Anonymous, Ethical guidelines for publication in Clinical Hemorheology and Microcirculation, Clin Hemorheol Microcirc63(1) (2016), 1–2.
14.
SeitzK., StrobelD., BernatikT., BlankW., Friedrich-RustM., HerbayA., et al., Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos, Ultraschall in der Medizin30(4) (2009), 383–389.
15.
BoozariB., LotzJ., GalanskiM. and GebelM., Diagnostic imaging of liver tumours, Current status. Der Internist48(1) (2007), 8, 10-2, 4-6, 8-20.
16.
PiscagliaF. and BolondiL., Italian Society for Ultrasound in M and Biology Study Group on Ultrasound Contrast A, The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations, Ultrasound in Medicine & Biology32(9) (2006), 1369–1375.
17.
WestwoodM., JooreM., GruttersJ., RedekopK., ArmstrongN., LeeK., et al., Contrast-enhanced ultrasound using SonoVue(R) (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: A systematic review and cost-effectiveness analysis, Health Technol Assess17(16) (2013), 1–243.
18.
ClevertD.A., JungE.M., StockK.F., WeckbachS., FeuerbachS., ReiserM., et al., Evaluation of malignant liver tumors: Biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound, Z Gastroenterol47(12) (2009), 1195–1202.
